Clinical trial
Functional and Metabolic Effects of Fonte Fausta® Water on the Musculoskeletal System in Patients with Osteoporosis/Osteopenia with or Without Sarcopenia
NCT06851676 is registered in ClinicalTrials.gov with ANTIMO as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional and Metabolic Effects of Fonte Fausta® Water on the Musculoskeletal System in Patients with Osteoporosis/Osteopenia with or Without Sarcopenia
- Lead sponsor
- ANTIMO
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 10, 2024
- Completion date
- September 10, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteopenia, osteoporosis, sarcopenia